Influence of Inotropic Choice on Morbidity and Mortality in Complex Pediatric Heart Surgery

NCT04380181 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2020-06-11

No results posted yet for this study

Summary

Our study is based on the observation that management of the cardiopulmonary by-pass withdrawal in pediatric heart surgery is quite variable between medical teams.

Indeed, in our center (HUDERF), the most common inotropic plan is dobutamine only or combination of milrinone and adrenalin but their uses seem to be very anesthesiologist dependent.

Despite the lack of sufficient evidence, the choice is probably multi-factorial, based mainly on the inotrope pharmacology, the patient physiopathology and the anesthesiologist preference.

The aim of this study is to determine if one of these inotropic strategy (dobutamine VS milrinone + adrenaline) is better compared to the other in terms of morbi-mortality.

In order to do that, the investigators will realize a retrospective study based on files from January 2008 to December 2018 concerning 250 selected patients.

Conditions

  • Pediatric Cardiac Surgery

Interventions

DRUG

dobu

Use of dobutamine versus milrinone and epinephrine for separation from cardiopulmonary bypass

Sponsors & Collaborators

  • Queen Fabiola Children's University Hospital

    collaborator OTHER
  • Brugmann University Hospital

    lead OTHER

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-11
Primary Completion
2020-06-05
Completion
2020-06-10

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04380181 on ClinicalTrials.gov